Donald A. Ludwig
Corporate Officer/Principal chez VIVOS INC.
Profil
Donald A.
Ludwig is currently the Director & Executive Vice President at Molecular Diagnostics & Therapeutics, Inc. and the Director-Special Projects at Vivos, Inc. He holds an MBA from the University of Southern California, a doctorate from the University of California, Los Angeles, a graduate degree from the California Institute of Technology, and an undergraduate degree from the US Military Academy.
Postes actifs de Donald A. Ludwig
| Sociétés | Poste | Début |
|---|---|---|
| VIVOS INC. | Corporate Officer/Principal | - |
Molecular Diagnostics & Therapeutics, Inc.
 Molecular Diagnostics & Therapeutics, Inc. Medical SpecialtiesHealth Technology Molecular Diagnostics & Therapeutics, Inc. manufactures and distributes nuclear medicines. Its products include sodium iodide, palladium, thallium, thallous chloride, technetium and pet products. The company on February 19, 1992 and is headquartered in Longmont, CO. | Directeur/Membre du Conseil | - |
Formation de Donald A. Ludwig
| University of California, Los Angeles | Doctorate Degree |
| US Military Academy | Undergraduate Degree |
| California Institute of Technology | Graduate Degree |
| University of Southern California | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VIVOS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Molecular Diagnostics & Therapeutics, Inc.
Molecular Diagnostics & Therapeutics, Inc. Medical SpecialtiesHealth Technology Molecular Diagnostics & Therapeutics, Inc. manufactures and distributes nuclear medicines. Its products include sodium iodide, palladium, thallium, thallous chloride, technetium and pet products. The company on February 19, 1992 and is headquartered in Longmont, CO. | Health Technology |